Dorrapharma is engaged in R&D, manufacture and market of intermediate, API (Active Pharmaceutical Ingredients) and formulation. We stick to raise the value both for the company and customer, and strive for serving for the society and caring of the others. We devote ourselves completely to the technology innovation and brand build, and make every effort to foster the core competence for the company. We are in a progress of becoming a global leading pharmaceutical server.The operation strategy is to be driven by R&D and promoted by market and quality assurance. We have built up R&D center at Shanghai in 2009, and kept close cooperation and deep communication with first class institution at home and abroad. The API and formulation sites are approved by Chinese SFDA, ISO9001, European cGMP, US FDA, Australia TGA and etc. The therapeutic areas cover anti-infection, anti-virus, diabetes treatment, cardiovascular system, digestive system and etc. With good reputation, our products are supplied to the countries and areas such as Europe, America, and Southeast Asia.We are consecutive to concern about the public and repay the society with strong responsibility and social mission along with development of our company. Based on integrity and innovation, we are committed to build up our own brand, make great performance and contribute to the happiness of human life.
